SCHEMBL19080025

SCHEMBL19080025

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5c(c4)c4ccccc4c4c6cc7ccccc7cc6oc54)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.35
ESR2 Q92731 6/20 0.35
ARSA P15289 1/20 0.32
CDC25A P30304 1/20 0.32
CDC25C P30307 1/20 0.32
ALOX5 P09917 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALPI P09923 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.32
CASP3 P42574 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
CASP7 P55210 1/20 0.32
CASP6 P55212 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080085 0.92 CYP1A1 (0.35) ARSACDC25ACDC25CALOX5SOS1
SCHEMBL19080028 0.92 ESR1 (0.36) ESR1ESR2ARSACDC25ACDC25C
SCHEMBL19080053 0.91 ALOX5 (0.36) ARSACDC25ACDC25CALOX5KDM4E
SCHEMBL19079943 0.90 ESR1 (0.38) ESR1ESR2ALOX5MEN1KMT2A
SCHEMBL19080040 0.88 ESR1 (0.37) ESR1ESR2MEN1KMT2AKDM4E
SCHEMBL17931964 0.88 ALOX5 (0.39) CDC25ACDC25CALOX5MEN1KMT2A
SCHEMBL17931965 0.88 ALOX5 (0.35) ESR1ESR2ARSACDC25ACDC25C
SCHEMBL17944133 0.88 ALOX5 (0.38) ALOX5MEN1KMT2AKDM4ECYP3A4
SCHEMBL19079964 0.87 PSD (0.34) ARSACDC25ACDC25CALOX5KDM4E
SCHEMBL19080091 0.87 GPR84 (0.35) ARSACDC25ACDC25CALOX5SOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ESR1 153/4885ESR2 510/4885ARSA 4452/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ESR1 153/4885ESR2 510/4885ARSA 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.